Simon F Müller Selected Research

Peptides (Polypeptides)

1/2021	Long-term trans-inhibition of the hepatitis B and D virus receptor NTCP by taurolithocholic acid.
1/2018	Characterisation of the hepatitis B virus cross-species transmission pattern via Na+/taurocholate co-transporting polypeptides from 11 New World and Old World primate species.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon F Müller Research Topics

Disease

2	Hepatitis B 01/2021 - 01/2018
2	Infections 01/2021 - 01/2018
1	Chronic Renal Insufficiency 06/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Cholestasis 01/2021
1	Overactive Urinary Bladder (Overactive Bladder) 12/2020
1	Hepatitis D 01/2018

Drug/Important Bio-Agent (IBA)

2	Peptides (Polypeptides)IBA 01/2021 - 01/2018
2	Taurocholic Acid (Sodium Taurocholate)IBA 01/2021 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2021
1	Hormones (Hormone)IBA 06/2023
1	Fibroblast Growth Factor-23IBA 06/2023
1	bile acid binding proteinsIBA 01/2021
1	doramectinIBA 01/2021
1	Virus ReceptorsIBA 01/2021
1	Taurolithocholic AcidIBA 01/2021
1	trospium chloride (Ceris)FDA LinkGeneric 12/2020
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2020
1	Arginine (L-Arginine)FDA Link 01/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2020